Survey of care provided by ambulatory care pharmacists to patients with chronic kidney disease

Bennett, Robin E.; DeHart, Renee M.; Lauderdale, Stacy A.

doi:10.2146/ajhp050522

Cited by 5 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…8,[11][12][13][14][15] More specific to renal pharmacy, some renal pharmacists are not aware of evidence-based guidelines for clinical practice. 16 It is essential to close the know-do gap with respect to renal QI-DTPs, to ensure that patients with renal disease who have prevalent and impactful drug therapy needs receive high-quality pharmaceutical care. There has been some research on the interventions that renal pharmacists should perform, but there are few high-quality studies that address the effects of such interventions in renal patients.…”

Section: Introductionmentioning

confidence: 99%

Barriers to and Enablers of Implementation of High-Value Interventions by Renal Pharmacists: A Qualitative Study Informed by the Theoretical Domains Framework

Nevers

Ratcheva

Boutin

et al. 2020

CJHP

View full text Add to dashboard Cite

Background: Previous studies have shown that patients with chronic kidney disease who are followed by a renal clinical pharmacist have improved clinical outcomes. In 2016, a consensus list of quality indicator drug therapy problems (QI-DTPs) was developed by renal clinical pharmacists to help prioritize which renal patients should receive interventions. Before QI-DTP interventions can be implemented in clinical practice, barriers to and enablers of their use need to be identified, to allow development of strategies to overcome the barriers and apply the enablers.Objective: To identify modifiable barriers to and enablers of implementation of renal QI-DTP interventions by renal clinical pharmacists.Methods: In this exploratory qualitative descriptive study, one-on-one, semistructured, audio-recorded telephone interviews were conducted with renal clinical pharmacists to identify the barriers to and enablers of implementation of renal QI-DTP interventions. The interviews consisted of questions developed according to the Theoretical Domains Framework.Results: Interviews were conducted with 13 renal pharmacists from across Canada. The main barriers to implementation of renal QI-DTP interventions that participants identified were knowledge gaps, prioritization, and nephrologist acceptance. The main enablers identified were training, colleague support, and better patient care.Conclusion: Three barriers to and three enablers of implementation of renal QI-DTP interventions were identified. These barriers and enablers can be used to help with pharmacist education and to optimize the care that pharmacists provide to renal patients.RÉSUMÉContexte : Des études précédentes démontrent une amélioration des résultats cliniques de patients souffrant d’une maladie rénale chronique, qui sont suivis par un pharmacien clinicien en néphrologie. En 2016, des pharmaciens cliniciens en néphrologie ont mis au point une liste consensuelle des indicateurs de qualité des problèmes de pharmacothérapie (QI-DTP) pour les aider à prioriser les patients souffrant d’une insuffisance rénale, qui doivent subir une intervention. Avant de mettre en place ces QI-DTP en pratique clinique, on doit déterminer les éléments qui entravent et facilitent leur utilisation pour pouvoir élaborer des stratégies visant à surmonter les obstacles et à appliquer les éléments facilitateurs.Objectif :Déterminer les éléments modifiables qui entravent et facilitent la mise en place des QI-DTP par les pharmaciens cliniciens en néphrologie lors d’interventions rénales.Méthodes : Dans cette étude exploratoire, descriptive et qualitative, des entretiens téléphoniques individuels, semi structurés et enregistrés ont été menés auprès de pharmaciens cliniciens en néphrologie pour determiner les éléments qui entravent et facilitent la mise en place de QI-DTP lors d’interventions rénales. Les entretiens consistaient en des questions préparées selon le Theoretical Domains Framework.Résultats : Les entretiens ont été menés auprès de 13 pharmaciens en néphrologie de partout au Canada. Les principaux éléments entravant la mise en place de QI-DTP lors d’interventions rénales déterminées par les participants étaient : le manque de connaissances, la priorisation et l’acception des néphrologues. Les principaux éléments facilitant la tâche étaient : la formation, le soutien des collègues et de meilleurs soins offerts aux patients.Conclusion : Trois éléments entravant et trois éléments facilitant la mise en place de QI-DTP lors d’interventions rénales ont été déterminés. Ils peuvent être utilisés pour contribuer à la formation du pharmacien et pour optimiser les soins offerts aux patients qui souffrent d’insuffisance rénale.

show abstract

Section: Introductionmentioning

confidence: 99%

Barriers to and Enablers of Implementation of High-Value Interventions by Renal Pharmacists: A Qualitative Study Informed by the Theoretical Domains Framework

Nevers

Ratcheva

Boutin

et al. 2020

CJHP

View full text Add to dashboard Cite

show abstract

“…A survey [8] of pre-dialysis care indicated that only a small portion of ambulatory care pharmacists monitored the areas recommended by the Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines [9][10][11][12]. The delivery of CKD care, as monitored using administrative data, is suboptimal when compared to the guidelines recommendations [13].…”

Section: Introductionmentioning

confidence: 99%

Evaluation of a training and communication-network nephrology program for community pharmacists

Lalonde

Normandeau²,

Lamarre

et al. 2008

Pharm World Sci

View full text Add to dashboard Cite

show abstract

Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines

Veer

Tomson

Jager

et al. 2013

Nephrology Dialysis Transplantation

View full text Add to dashboard Cite

Survey of care provided by ambulatory care pharmacists to patients with chronic kidney disease

Abstract: The ambulatory care pharmacists surveyed were not consistently involved in the routine monitoring of common complications of CKD.

Cited by 5 publications

References 7 publications

Barriers to and Enablers of Implementation of High-Value Interventions by Renal Pharmacists: A Qualitative Study Informed by the Theoretical Domains Framework

Barriers to and Enablers of Implementation of High-Value Interventions by Renal Pharmacists: A Qualitative Study Informed by the Theoretical Domains Framework

Evaluation of a training and communication-network nephrology program for community pharmacists

Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines

Contact Info

Product

Resources

About